Table 1.
Patient details.
| Case | Age (years) | Gender | Post-mortem delay (h:min) | Lesion stage |
|---|---|---|---|---|
| Ctrl 1 | 64 | M | 18:00 | NA |
| Ctrl 2 | 35 | M | 22:00 | NA |
| Ctrl 3 | 68 | M | 30:00 | NA |
| Ctrl 4 | 77 | M | 22:00 | NA |
| Ctrl 5 | 72 | F | 7:20 | NA |
| Ctrl 6 | 59 | M | 8:00 | NA |
| MS 1 | 35 | F | 09:00 | A |
| MS 2 | 53 | F | 17:00 | A |
| MS 3 | 39 | F | 09:00 | A |
| MS 4 | 77 | M | 04:15 | A |
| MS 5 | 47 | M | 10:00 | A |
| MS 6 | 48 | F | 9:20 | A, CA |
| MS 7 | 66 | F | 6:00 | CA |
| MS 8 | 51 | M | 11:00 | CA |
| MS 9 | 43 | M | 26:00 | CA |
| MS 10 | 40 | M | 27:00 | CA |
| MS 11 | 50 | F | 22:00 | CA |
Clinical data of MS (all SPMS) patients and non-neurological controls. M, male; F, female; A, active lesions; CA, chronic active lesions; NA, non-applicable.